This live web event has ended. Thank you for attending.
Non-cystic fibrosis bronchiectasis (NCFB) results from an initial airway
Injury that leads to a cycle of Inflammation, airway remodeling, Increased mucus production, and repeated Infection (Maselli 2017 p2). Repeated
infections, particularly with Pseudomonas aeruginosa,
have a significant impact on quality of life, number of hospitalizations, and
mortality in NCFB patients. Current approaches to treatment are associated with
suboptimal disease management, adverse events, and bacterial resistance. This
webinar will discuss how the severity of NCFB is characterized, current challenges
in diagnosis and management, and emerging treatment strategies for severe NCFB.
This program is sponsored by Zambon
By registering for this webinar, you agree your information will be shared with the sponsor.
No CME or MOC credits are available for this program.
Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.